Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

ClinicalTrials.gov ID: NCT00413218

Public ClinicalTrials.gov record NCT00413218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections

Study identification

NCT ID
NCT00413218
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

  • Isavuconazole Drug
  • Caspofungin Drug
  • Voriconazole Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2007
Primary completion
Mar 2, 2015
Completion
Mar 2, 2015
Last update posted
Dec 9, 2024

2007 – 2015

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-0006
Somero Research Corporation Palm Desert California 92211
University of California Davis Health System Sacramento California 95817
University of California at San Francisco San Francisco California 94143
Idaho Falls Infectious Diseases PLLC Idaho Falls Idaho 83404
Loyola University Hospital Maywood Illinois 60153
Springfield Clinic LLP Springfield Illinois 62701
Infectious Disease of Indiana Indianapolis Indiana 46280
Ochsner Clinic Foundation New Orleans Louisiana 70121
University of Maryland School of Medicine Baltimore Maryland 21201
UMASS Memorial Medical Center Worcester Massachusetts 01655
Henry Ford Hospital Detroit Michigan 48202
Mercury Street Medical Group Butte Montana 59701
Jersey Shore University Medical Center Neptune City New Jersey 07753
New York Presbyterian Hospital New York New York 10065
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Regional Infection Diseases Infusion Center Inc. Lima Ohio 45801
Temple University Health Sciences Philadelphia Pennsylvania 19140

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00413218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00413218 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →